RSS feed (help and list of feeds)
Consultation
We ask for feedback on proposals through public consultation, and take into account all consultation responses we receive before making our decisions. PHARMAC has published guidance for consumers on getting involved in our decisions, and this includes responses to consultation. You can download the document here (8 pages, 100 KB).
We welcome feedback from pharmaceutical suppliers, health professionals, health interest groups and the general public. This page includes consultations that are currently underway.
You can respond to a consultation by writing to the address at the bottom of the consultation letter. Notifications of the outcomes of closed consultations are available here.
Rapid response
If you would like to make a rapid response to any of our consultations, click 
here. Remember to indicate which consultation proposal your comments relate to.
Search for previous consultation documents
-
Update letter to diabetes consultation (1 page, 116 KB)
-
Title Proposal regarding a number of Abbott's Nutritional products (3 pages, 126 KB) Closing Date Tuesday 29 May 2012 Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Proposal to list NovoMix 30, NovoSeven RT and amend listing for Glucagen Hypokit (3 pages, 134 KB) Closing Date Closed Contact Natalie Davis Email Natalie.Davis@pharmac.govt.nz
-
Title Proposal to amend the funding access criteria for some Nutritional Products (3 pages, 119 KB) Closing Date Closed Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Proposal to list buprenorphine with naloxone (Suboxone) (3 pages, 118 KB) Closing Date Closed Contact Sue Anne Yee Email SueAnne.Yee@pharmac.govt.nz
-
Title Proposal to widen access to prasugrel (2 pages, 112 KB) Closing Date Closed Contact Sue Anne Yee Email SueAnne.Yee@pharmac.govt.nz
-
Title Proposal to list Accu-Chek Ketur-Test (1 page, 111 KB) Closing Date Closed Contact Natalie Davis Email Natalie.Davis@pharmac.govt.nz
-
Title Additional Proposals relating to Dispensing Frequency Rule & Access Exemption Rule (4 pages, 162 KB) Closing Date Closed Contact Rachel Mackay Email Rachel.Mackay@pharmac.govt.nz
-
Title Review of Dispensing Frequency for Monthly Medicines (4 pages, 74 KB) Closing Date Closed Contact Rachel Mackay Email Rachel.Mackay@pharmac.govt.nz
-
PHARMAC’s Operating Policies and Procedures: What's in? What's out? (9 pages, 1981 KB)
-
Title Proposal to list parecoxib sodium (Dynastat) (2 pages, 127 KB) Closing Date Closed Contact Jackie Evans Email Jackie.Evans@pharmac.govt.nz
-
Title Proposed changes to the Pharmaceutical Schedule Rules (7 pages, 182 KB) Closing Date Closed Contact Rachel Mackay Email Rachel.Mackay@pharmac.govt.nz
-
Title Proposal to list insulin pumps and consumables (5 pages, 128 KB) Closing Date Closed Contact diabetesfeedback Email diabetesfeedback@pharmac.govt.nz
-
Title Consultation for changes to prescriber types (4 pages, 139 KB) Closing Date Closed Contact Rebecca Bloor Email Rebecca.Bloor@pharmac.govt.nz
-
Title Proposals relating to multiple diabetes management products (5 pages, 145 KB) Closing Date Closed Contact diabetesfeedback Email diabetesfeedback@pharmac.govt.nz
-
Title Amend the listing relating to Ranbaxy-Cefaclor 250mg capsules (2 pages, 112 KB) Closing Date Closed Contact Greg Williams Email Greg.Williams@pharmac.govt.nz
-
Title Proposal to fund a number of nutritional products (6 pages, 153 KB) Closing Date Closed Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Changes to infant formula for premature infants (3 pages, 121 KB) Closing Date Closed Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Proposal to amend the listing of benztropine mesylate injections (2 pages, 110 KB) Closing Date Closed Contact Natalie Davis Email Natalie.Davis@pharmac.govt.nz
-
Title Feedback on draft Records Retention and Disposal Schedule (1 page, 79 KB) Closing Date Closed Contact Davina Carpenter Email Davina.Carpenter@pharmac.govt.nz
Page updated on 22 May 2012
Linked documents
Having Your Say in our Decisions (8 pages, 100 KB)
Pharmaceutical Management Agency Having your say in our decisions PHARMAC’s decision-making PHARMAC is the Government agency that decides which medicines are funded for New Zealanders. We welcome input from people into our decision-making processes. There are a number of ways…
Update letter to diabetes consultation (1 page, 116 KB)
11 May 2012 Update on diabetes management products proposals We are continuing to work through the issues raised in the very wide-ranging responses to our consultation on blood glucose testing meters and strips. I wanted to give you a brief…
Proposal regarding a number of Abbott's Nutritional products; Closing Date: Tuesday 29 May 2012; Contact: Stephen Woodruffe (3 pages, 126 KB)
14 May 2012 Proposal regarding a number of Abbott’s Nutritional products (Special Foods) and reference pricing of Amino Acid Infant formula PHARMAC is seeking feedback on a proposal regarding the funding of a number of nutritional products (Special Foods). This…
Proposal to list NovoMix 30, NovoSeven RT and amend listing for Glucagen Hypokit; Closing Date: Closed; Contact: Natalie Davis (3 pages, 134 KB)
2 May 2012 Proposal to list NovoMix 30 and NovoSeven RT and to amend listing for Glucagen Hypokit PHARMAC is seeking feedback on a proposal to fund NovoMix 30 FlexPen and NovoSeven RT and to amend the listing for Glucagen…
Proposal to amend the funding access criteria for some Nutritional Products; Closing Date: Closed; Contact: Stephen Woodruffe (3 pages, 119 KB)
26 April 2012 Proposal to amend the funding access criteria for some Nutritional Products (Special Foods) PHARMAC is seeking feedback on several proposals relating to the access of funding for some nutritional products (Special Foods). In summary, these proposals would…
Proposal to list buprenorphine with naloxone (Suboxone); Closing Date: Closed; Contact: Sue Anne Yee (3 pages, 118 KB)
23 April 2012 Proposal to list buprenorphine with naloxone (Suboxone) PHARMAC is seeking feedback on a proposal to fund buprenorphine with naloxone (Suboxone) sublingual tablets through a provisional agreement with Reckitt Benckiser Pharmaceuticals. In summary, this proposal would result in…
Proposal to widen access to prasugrel; Closing Date: Closed; Contact: Sue Anne Yee (2 pages, 112 KB)
20 April 2012 Proposal to widen access to prasugrel PHARMAC is seeking feedback on a proposal to widen access to funded prasugrel from 1 June 2012 for patients who experience cardiac stent thrombosis whilst on clopidogrel. Feedback sought PHARMAC welcomes…
Proposal to list Accu-Chek Ketur-Test; Closing Date: Closed; Contact: Natalie Davis (1 page, 111 KB)
12 April 2012 Proposal to list Accu-Chek Ketur-Test Following a Request for Proposals (RFP) for the supply of diabetes management products dated 26 August 2011, PHARMAC has entered into a provisional agreement with Roche Diagnostics NZ to list Accu-Chek Ketur-Test…
Additional Proposals relating to Dispensing Frequency Rule & Access Exemption Rule; Closing Date: Closed; Contact: Rachel Mackay (4 pages, 162 KB)
5 April 2012 Additional Proposals relating to Dispensing Frequency (Close Control) Rule & Access Exemption Rule PHARMAC is currently consulting on a proposal to change the Pharmaceutical Schedule rules relating to Dispensing Frequency (Close Control). The intent of that proposal…
Review of Dispensing Frequency for Monthly Medicines; Closing Date: Closed; Contact: Rachel Mackay (4 pages, 74 KB)
5 April 2012 Review of Dispensing Frequency for Monthly Medicines PHARMAC is seeking feedback on a proposal to make changes to the list of pharmaceuticals that must be dispensed in 90 day lots (all-at-once or ‘stat’). We aim to reduce…
PHARMAC’s Operating Policies and Procedures: What's in? What's out? (9 pages, 1981 KB)
PHARMAC's Operating Policies and Procedures What's in? What's out? Discussion document April 2012 3 April 2012 An invitation from the Acting Chief Executive Thank you for taking the time to read and respond to this discussion document seeking your views…
Proposal to list parecoxib sodium (Dynastat); Closing Date: Closed; Contact: Jackie Evans (2 pages, 127 KB)
29 March 2012 Proposal to list parecoxib sodium (Dynastat) in Section H of the Pharmaceutical Schedule PHARMAC is seeking feedback on a proposal to: list parecoxib sodium 40 mg powder for injection (Dynastat) in Part II of Section…
Proposed changes to the Pharmaceutical Schedule Rules; Closing Date: Closed; Contact: Rachel Mackay (7 pages, 182 KB)
28 March 2012 PROPOSED CHANGES TO THE PHARMACEUTICAL SCHEDULE RULES RELATING TO DISPENSING FREQUENCY Introduction DHBs have undertaken extensive engagement with the sector to consider reconfiguration of community pharmacy services. Their objective is to develop a new tiered patient-centred service…
Proposal to list insulin pumps and consumables; Closing Date: Closed; Contact: diabetesfeedback (5 pages, 128 KB)
27 February 2012 Proposal to list insulin pumps and consumables As a result of a Request for Proposals (RFP) for the supply of diabetes management products dated 26 August 2011, PHARMAC has entered into a provisional agreement with New Zealand…
Consultation for changes to prescriber types; Closing Date: Closed; Contact: Rebecca Bloor (4 pages, 139 KB)
23 February 2012 Proposal to amend definitions of prescriber types in the Pharmaceutical Schedule and to apply these definitions to Special Authorities The prescriber restriction review has been ongoing for some time. Over this time we have made changes to…
Proposals relating to multiple diabetes management products; Closing Date: Closed; Contact: diabetesfeedback (5 pages, 145 KB)
23 February 2012 Proposals relating to multiple diabetes management products As a result of a Request for Proposals (RFP) for the supply of diabetes management products dated 26 August 2011, PHARMAC has entered into a provisional agreement with Pharmaco NZ…
Amend the listing relating to Ranbaxy-Cefaclor 250mg capsules; Closing Date: Closed; Contact: Greg Williams (2 pages, 112 KB)
17 February 2012 Proposal to amend the listing relating to Ranbaxy-Cefaclor 250 mg capsules PHARMAC is seeking feedback on a proposal to amend the listing relating to RanbaxyCefaclor 250mg capsules through a provisional agreement with Douglas Pharmaceuticals Ltd. In summary,…
Proposal to fund a number of nutritional products; Closing Date: Closed; Contact: Stephen Woodruffe (6 pages, 153 KB)
16 February 2012 Proposal to fund a number of Nutritional products (Special Foods) supplied by Nutricia PHARMAC is seeking feedback on a proposal to fund a number of nutritional products (Special Foods) supplied by Nutricia from 1 April 2012. In…
Changes to infant formula for premature infants; Closing Date: Closed; Contact: Stephen Woodruffe (3 pages, 121 KB)
14 February 2012 Changes to the infant formula funded for use in premature infants when discharged from hospital PHARMAC is seeking feedback on a proposal to replace the low birth weight formula (S-26 Gold LBW RTF) that is currently funded…
Proposal to amend the listing of benztropine mesylate injections; Closing Date: Closed; Contact: Natalie Davis (2 pages, 110 KB)
5 December 2011 Proposal to amend the listing of benztropine mesylate injections PHARMAC has signed a provisional agreement with Invida Australia Pty Ltd and is seeking feedback on the following proposals relating to benztropine mesylate (Cogentin) injections: benztropine mesylate…
Feedback on draft Records Retention and Disposal Schedule; Closing Date: Closed; Contact: Davina Carpenter (1 page, 79 KB)
28 November 2011 Feedback on draft Records Retention and Disposal Schedule PHARMAC is seeking feedback on our records retention and disposal schedule and the report that must accompany the schedule when it is submitted to Archives New Zealand. In summary,…
